Article

Updating TCGA glioma classification through integration of molecular profiling data following the 2016 and 2021 WHO guidelines

2023-02-21

Abstract excerpt

The understanding of glioma disease has been evolving drastically with dedicated research into the genetic and molecular profiling of glioma tumour tissue. Molecular biomarkers have gained progressive and substantial importance in providing diagnostic information, leading to groundbreaking changes in the tumour classification system, criteria and taxonomy standardised by the 2016 and 2021 editions of the World Hea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 21c1f7e0-e9ae-5d94-b16a-e87a430e0d16
DOI: 10.1101/2023.02.19.529134

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Updating TCGA glioma classification through integration of molecular profiling data following the 2016 and 2021 WHO guidelinesDOI 10.1101/2023.02.19.529134Read

Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification.Semantic proximity Read

[Evolution of Glioma Diagnosis: The WHO 2021 Classification and Beyond].Semantic proximity Read

Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.Semantic proximity Read

The Glioma-IRE project - Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach.Semantic proximity Read

Computational genomics of brain tumors: identification and characterization of glioma candidate biomarkers through multi-omics integrative molecular profilingSemantic proximity Read

Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric studySemantic proximity Read

Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors.Semantic proximity Read

Multi-omics biomarker selection and outlier detection across WHO glioma classifications via robust sparse multinomial regressionSemantic proximity Read

Real-life implementation of molecular criteria for diagnosing gliomas according to 2021 WHO Classification: a national survey from the Italian Association of Neuro-Oncology and Society of Neurosurgery.Semantic proximity Read

Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.Semantic proximity Read

Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics.Semantic proximity Read